Spero Therapeutics Inc.

0.75
0.01 (1.35%)
At close: Apr 17, 2025, 3:59 PM
0.73
-2.55%
After-hours: Apr 17, 2025, 05:33 PM EDT

Spero Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
47.98M 96.73M 48.58M 18.26M 9.33M 4.74M 3.97M 1.98M 335K
n/a 367K 1.55M 1.12M 67M 65.78M 33.88M 32.87M 26.33M
47.98M 96.37M 47.03M 17.14M -57.67M -61.03M -29.92M -30.89M -26M
-73.36M 21.48M -42.2M -87.97M -79.11M -63.22M -42.81M -41.73M -33.22M
4.74M 3.94M 1.11M 346K 401K 1.33M 1.14M 303K n/a
-68.57M 25.4M -46.41M -89.76M -78.28M -60.92M -41.66M -46.1M -32.64M
-68.57M 22.81M -48.03M -91.3M -77.52M -60.17M -41.66M -46.1M -25.49M
23.7M 25.55M 36.48M 41.7M 21.44M 15.59M 12.89M 10.84M 7.22M
96.76M 51.44M 47.59M 64.53M 67M 65.78M 33.88M 32.87M 26.33M
877K -1.74M -4.93M -395K 833K -13.4M 1.14M -4.37M n/a
121.34M 75.25M 79.15M 106.23M 88.44M 67.96M 42.81M 41.73M 33.56M
n/a n/a 2.6M 1.94M n/a n/a 303K 303K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
121.34M 75.25M 79.15M 106.23M 88.44M 67.96M 42.81M 41.73M 33.56M
n/a 2.6M 1.61M 1.54M -761K -750K 1.14M -363K -7.73M
54.04M 52.7M 37.59M 30.9M 22.39M 18.16M 16M 2.59M 6.6M
54.04M 52.99M 37.59M 30.9M 22.39M 18.16M 16M 2.59M 6.6M
-1.27 0.43 -1.28 -2.96 -3.46 -3.31 -2.6 -17.82 -3.86
-1.27 0.43 -1.28 -2.96 -3.46 -3.31 -2.6 -17.82 -3.86
-72.48M 25.77M -42.26M -87.17M -76.93M -62.47M -42.4M -41.37M -32.94M
-72.48M 25.4M -43.81M -87.82M -78.28M -63.22M -42.81M -41.73M -33.22M
2K 367K 1.55M 1.12M 1.35M 1.16M 409K 363K 279K